
|Articles|June 18, 2015
PAREXEL Enhances Data-Driven Monitoring
Advertisement
PAREXEL has added risk-based monitoring capabilities, expanding its Perceptive MyTrials® Data-Driven Monitoring (DDM) solution. Data-Driven Monitoring now further enables clients to perform cross-study analysis of quality, risk, and monitoring work effort by combining analytics, reporting and monitoring activity into a single cohesive solution. The enhancements increase the ability to demonstrate appropriate oversight and control of site-related risk, quality, and performance while simplifying monitoring governance and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway
2
Where AI Is Delivering Real Value in Clinical Trial Payments Right Now
3
Inspection Readiness Is Not a Pre-Inspection Activity, It's an Execution Design Condition
4
From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance
5




